Primary outcome measures: (1) participant ratings of convenience, effort required, and satisfaction with the intervention, (2) knowledge about prostate cancer screening and treatment, and (3) choice of undergoing PSA test. The gene discussed is KLK3; the disease is prostate carcinoma.